Drug price history · CMS NADAC read 11 November 2026
Generic
$0.830 per mL at the 2013 year-end survey (4 NDCs) and $0.255 at the 2026 survey (9 NDCs): −69%.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.830 | 4 | |
| 2014 (2014-12-31) | $0.769 | $0.656 to $0.769 | 6 |
| 2015 (2015-12-30) | $0.597 | $0.597 to $0.735 | 5 |
| 2016 (2016-12-28) | $0.594 | $0.594 to $0.694 | 9 |
| 2017 (2017-12-27) | $0.535 | 8 | |
| 2018 (2018-12-26) | $0.535 | 7 | |
| 2019 (2019-12-25) | $0.444 | $0.444 to $0.456 | 6 |
| 2020 (2020-12-30) | $0.447 | $0.351 to $0.453 | 7 |
| 2021 (2021-12-29) | $0.492 | 3 | |
| 2022 (2022-12-28) | $0.234 | $0.234 to $0.337 | 11 |
| 2023 (2023-12-27) | $0.319 | $0.319 to $0.331 | 9 |
| 2024 (2024-12-25) | $0.268 | $0.268 to $0.290 | 9 |
| 2025 (2025-12-31) | $0.248 | $0.248 to $0.337 | 9 |
| 2026 (2026-11-11) | $0.255 | $0.255 to $0.297 | 9 |
Generic
$0.982 per mL at the 2013 year-end survey (5 NDCs) and $0.255 at the 2026 survey (9 NDCs): −74%.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.982 | 5 | |
| 2014 (2014-12-31) | $0.697 | $0.514 to $0.697 | 8 |
| 2015 (2015-12-30) | $0.625 | $0.620 to $0.933 | 9 |
| 2016 (2016-12-28) | $0.542 | $0.542 to $0.579 | 10 |
| 2017 (2017-12-27) | $0.427 | 8 | |
| 2018 (2018-12-26) | $0.372 | $0.276 to $0.372 | 11 |
| 2019 (2019-12-25) | $0.351 | $0.269 to $0.351 | 11 |
| 2020 (2020-12-30) | $0.355 | $0.332 to $0.383 | 9 |
| 2021 (2021-12-29) | $0.329 | $0.329 to $0.367 | 13 |
| 2022 (2022-12-28) | $0.255 | $0.255 to $0.365 | 10 |
| 2023 (2023-12-27) | $0.288 | $0.288 to $0.353 | 9 |
| 2024 (2024-12-25) | $0.268 | $0.268 to $0.291 | 9 |
| 2025 (2025-12-31) | $0.244 | $0.244 to $0.365 | 9 |
| 2026 (2026-11-11) | $0.255 | $0.255 to $0.303 | 9 |
Generic
$0.971 per mL at the 2013 year-end survey (4 NDCs) and $0.274 at the 2026 survey (9 NDCs): −72%.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.971 | 4 | |
| 2014 (2014-12-31) | $0.662 | 6 | |
| 2015 (2015-12-30) | $0.630 | $0.602 to $0.878 | 9 |
| 2016 (2016-12-28) | $0.654 | $0.654 to $0.740 | 10 |
| 2017 (2017-12-27) | $0.401 | 8 | |
| 2018 (2018-12-26) | $0.411 | $0.255 to $0.411 | 9 |
| 2019 (2019-12-25) | $0.392 | $0.275 to $0.422 | 9 |
| 2020 (2020-12-30) | $0.346 | $0.312 to $0.449 | 9 |
| 2021 (2021-12-29) | $0.277 | $0.277 to $0.401 | 13 |
| 2022 (2022-12-28) | $0.256 | $0.256 to $0.347 | 10 |
| 2023 (2023-12-27) | $0.275 | $0.275 to $0.391 | 9 |
| 2024 (2024-12-25) | $0.267 | $0.267 to $0.293 | 9 |
| 2025 (2025-12-31) | $0.267 | $0.267 to $0.437 | 9 |
| 2026 (2026-11-11) | $0.274 | $0.274 to $0.377 | 9 |
CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.
The FDA Orange Book lists no generic maker as marketed for Levalbuterol. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.
Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. For who makes the generic and which patents are listed, see the generic competition check for Levalbuterol on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).